Loading...
Artonin E sensitizes TRAIL-induced apoptosis by DR5 upregulation and cFLIP downregulation in TRAIL-refractory colorectal cancer LoVo cells
BACKGROUND: The TRAIL treatment is an ideal strategy for colorectal cancer (CRC) therapy because of minimal collateral damage to normal cells. Unfortunately, some CRC is TRAIL-refractory cancer, such as LoVo cells. In an effort to overcome TRAIL-refractory cancer, we investigated the effect of arton...
Na minha lista:
| Udgivet i: | J Gastrointest Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6465495/ https://ncbi.nlm.nih.gov/pubmed/31032087 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2018.12.02 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|